. Author manuscript; available in PMC: 2016 Mar 18.

Published in final edited form as: Inflamm Bowel Dis. 2010 Nov 9;17(7):1501–1512. doi: 10.1002/ibd.21525

Table 1. Various Dosing Regimens for VEGF₁₆₄ Aptamer during 6 Week T cell Colitis Model.

Dose Group	Total Amount	Time between injections	Total Amount Given
AMD Patient	0.3 mg	6 weeks	0.3 mg
Low	40 mg/kg	2 days	18 mg
Medium	80 mg/kg	2 days	36 mg
High	160 mg/kg	2 days	72 mg

The amount of the VEGF₁₆₄ aptamer (Macugen) given in AMD treatment, and the amount given in our low, medium, and high doses per day, the frequency of dosing, and the total dose given over a 6- week period.

Table 1. Various Dosing Regimens for VEGF164 Aptamer during 6 Week T cell Colitis Model.

Table 1. Various Dosing Regimens for VEGF₁₆₄ Aptamer during 6 Week T cell Colitis Model.